FactorPad
Build a Better Process

Stock Risk Measures for Ionis Pharmaceuticals Inc

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 66 for IONS below.

/ factorpad.com / stocks / f23cmt.html


An ad-free and cookie-free website.


IONS Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Ionis Pharmaceuticals Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how IONS stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f23cmt.html


IONS stock risk
IONIS PHARMACEUTICALS INC stock beta
IONS risk report
IONS f23cmt
IONS risk analysis
IONS volatility
IONIS PHARMACEUTICALS INC credit risk
IONS liquidity risk
IONS leverage
IONS valuation
IONS systematic risk
IONS specific risk
IONIS PHARMACEUTICALS INC volatility
IONS analysis
IONS financial ratio

A newly-updated free resource. Connect and refer a friend today.